Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA Approves Venetoclax for Chronic, Small Lymphocytic Leukemia

drugsMay 17, 2019

Tag: FDA , Venetoclax , Lymphocytic , leukemia

PharmaSources Customer Service